1. Home
  2. BOW vs ARQT Comparison

BOW vs ARQT Comparison

Compare BOW & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowhead Specialty Holdings Inc.

BOW

Bowhead Specialty Holdings Inc.

HOLD

Current Price

$27.85

Market Cap

913.3M

Sector

Finance

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$28.92

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOW
ARQT
Founded
2020
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
913.3M
3.3B
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
BOW
ARQT
Price
$27.85
$28.92
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$36.17
$24.83
AVG Volume (30 Days)
180.5K
2.4M
Earning Date
11-04-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
42.10
N/A
EPS
1.53
N/A
Revenue
$519,241,000.00
$317,929,000.00
Revenue This Year
$16.05
$85.51
Revenue Next Year
$21.18
$30.74
P/E Ratio
$18.17
N/A
Revenue Growth
33.44
129.21
52 Week Low
$23.50
$11.13
52 Week High
$42.29
$31.77

Technical Indicators

Market Signals
Indicator
BOW
ARQT
Relative Strength Index (RSI) 59.14 54.70
Support Level $25.20 $29.30
Resistance Level $27.74 $31.77
Average True Range (ATR) 0.80 1.13
MACD 0.03 -0.40
Stochastic Oscillator 86.12 15.99

Price Performance

Historical Comparison
BOW
ARQT

About BOW Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: